Health diagnostic startup Acculi Labs has secured $1.5 million in Seed Funding led by Sabi Holding India Ltd.
The fresh proceeds will be utilized to develop its AI insights system Lyra, and micro-entrepreneurial project Lyfas Udyam, and boost its JV with Sabi Holding with 50% being reserved for the latter and the rest for the former two. Additionally, manpower and operational efficiency, infrastructure development, and manufacturing capacity expansion are also being aimed at.
Bengaluru-based Acculi Labs was founded by Hari Prasath M and Rupam Das in 2017, offering point-of-care chronic disease diagnostics, monitoring, and healing. Lyfas is a mobile app that captures biomarkers non-invasively and prepares a detailed health report within three minutes. Lyfas Udyam enables small entrepreneurs to launch and grow their businesses.
“Our partnership with Acculi Labs has been instrumental in our growth. Our shared values and vision align perfectly, thereby making this investment a strategic move. We believe in Acculi’s potential and are excited about the future of our joint ventures.” said Sabi Holding India’s co-founder Kuldeep Dewa.
A report by Bain & Company suggests that healthcare innovation has helped the healthcare market grow by double from $3 billion in FY20 to $7 billion in FY23.
Healthcare service provider Lifetime Health raised $1.5 million in Seed Funding from Garage Syndicate while Icanheal raised Rs 15 crore in Seed Funding led by IvyCap Ventures.
